In 2014, the FDA began collaboration with French software company Dassault Systèmes and their simulated 3D heart model to test pacemakers and other cardiovascular devices. A recent Nextgov article discussed a new effort by the FDA to speed up the regulatory evaluation and approval process of medical devices and therapies that treat the heart. According to a request for information, the agency is now seeking a computational model of the entire human heart.
Companies in this article